D EPARTMENT OF H EALTH & HUMAN SERVICES Memorandum Food and Drug Administration Center for Biologics Evaluation and Research Bethesda, MD 20892 Date From : : June 20,…

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy GUIDEâ…

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbationsPreseasonal treatment with either omalizumab or an inhaled

Effects of omalizumab therapy on allergic rhinitis: a pilot study5249 Abstract. – OBJECTIVE: The use of omalizum- ab, a humanized monoclonal antibody able to bind-

doi:10.1016/j.jaci.2005.09.036Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis Thomas B. Casale,

doi:10.1016/j.jaci.2008.07.006Treatment of chronic autoimmune urticaria with omalizumab Allen P. Kaplan, MD,a,b Kusumam Joseph, PhD,b Robert J. Maykut, MD,c Gregory P. Geba,

Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental

Urticaria and Angioedema: an Update on Classification and PathogenesisZurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057

Christian VESTERGAARD1 Elias TOUBI2 Marcus MAURER3 Massimo TRIGGIANI4 Barbara BALLMER-WEBER5 Alexander MARSLAND6 Marta FERRER7 André KNULST8 Ana GIMÉNEZ-ARNAU9

SA Health Report Template - Blue and White - Helix Position APage 2 of 25 Summary of SAMEP review Receipt of High Cost Medicine (HCM) formulary application: 9th April 2014